Biotech stocks to watch in 2020
Dec 17, 2019
Dec 17, 2019 |
12 min
Finfeed runs the ruler over the biotech stocks to watch in 2020.
Prescient trials show total eradication of cancer
Nov 28, 2019
Nov 28, 2019 |
3 min
Shares in Prescient Therapeutics Limited (ASX:PTX) surged 50% on Wednesday after the clinical stage oncology company developing personalised medicine approaches to cancer released promising news.
Could a Loxo Oncology Style Trial, Bring Loxo Style Results for PTX?
Jan 31, 2019
Jan 31, 2019 |
10 min
Clinical stage oncology company, Prescient Therapeutics (ASX:PTX) is in a fortunate position. It has two clinical candidates, four trials, and multiple possible pathways to market for its targeted therapies that address specific mutations that drive cancer and contribute to resistance.
PTX is one step closer to finding a working cancer treatment
Jan 29, 2019
Jan 29, 2019 |
0.0 seconds
Prescient Therapeutics (ASX:PTX) CEO Steven Yatomi-Clarke speaks with Finfeed about the latest results in the company's cancer treatment trials.
